Wednesday, 28 February 2018

Why Oppenheimer Global fund is focusing on biotech as rates rise

NEW YORK (Reuters) - The recent volatility in the global stock market may make some investors feel queasy, but it is providing a buying opportunity in biotechnology stocks.


from Reuters: Business News http://ift.tt/2BU91oR

No comments:

Post a Comment

After seeing Parkinson's take his father, this Googler found a new mission: teaching AI to chase cures

Vivek Natarajan, a research scientist at Google DeepMind Vivek Natarajan Vivek Natarajan of Google DeepMind was inspired by his father's...